SCHEMBL5546097

SCHEMBL5546097

O=C(O)Oc1ncoc1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.54
FBP1 P09467 1/20 0.47
KDM4E B2RXH2 4/20 0.40
GSK3B P49841 2/20 0.39
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
HPGD P15428 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
NR4A2 P43354 2/20 0.37
PTPN1 P18031 1/20 0.37
PTGS1 P23219 1/20 0.36
GAA P10253 3/20 0.35
LMNA P02545 2/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16612946 0.89 ADORA2A (0.44) ADORA2AFBP1KDM4EALDH1A1KMT2A
SCHEMBL17746046 0.85 MAPK14 (0.45) ADORA2AFBP1KDM4EGSK3BALDH1A1
SCHEMBL16612795 0.84 KDM4E (0.43) ADORA2AKDM4EALDH1A1KMT2AMEN1
SCHEMBL16613030 0.84 KMO (0.42) ADORA2AKDM4EALDH1A1HSD17B10HCRTR1
SCHEMBL15189624 0.84 MEN1 (0.46) ADORA2AKDM4EALDH1A1KMT2AMEN1
SCHEMBL15189739 0.83 GSK3B (0.51) KDM4EGSK3BALDH1A1KMT2AMEN1
SCHEMBL16612942 0.82 GSK3B (0.47) ADORA2AGSK3BKMT2AMEN1PTPN1
SCHEMBL16612913 0.81 NOTUM (0.45) ADORA2AHCRTR2
SCHEMBL15189706 0.81 GSK3B (0.51) KDM4EGSK3BALDH1A1KMT2AMEN1
SCHEMBL16612964 0.80 NOTUM (0.44) ADORA2AKDM4EALDH1A1HCRTR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648724-B1 HYDROXYLATED AMINOTRIAZOLE DERIVATIVES AS ALX RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2016-09-21 EP claimed
EP-2440555-B1 FLUORINATED AMINOTRIAZOLE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2016-05-18 EP claimed
EP-2675801-B1 NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2015-04-08 EP claimed
EP-1742925-B1 SUBSTITUTED 5, 6, 7, 8-TETRAHYDRO-PYRIDO[4, 3-D]PYRIMIDINE-2-YL COMPOUNDS AND 5, 6, 7, 8-TETRAHYDRO-QUINAZOLINE-2-YL COMPOUNDS GRUENENTHAL GMBH (DE) 2014-04-23 EP claimed
EP-2242743-B1 AMINOPYRAZOLE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2013-08-21 EP claimed
EP-1742925-B1 SUBSTITUTED 5, 6, 7, 8-TETRAHYDRO-PYRIDO[4, 3-D]PYRIMIDINE-2-YL COMPOUNDS AND 5, 6, 7, 8-TETRAHYDRO-QUINAZOLINE-2-YL COMPOUNDS GRUENENTHAL GMBH (DE) 2014-04-23 EP disclosed
EP-1742925-A1 SUBSTITUTED 5, 6, 7, 8-TETRAHYDRO-PYRIDO[4, 3-D]PYRIMIDINE-2-YL COMPOUNDS AND 5, 6, 7, 8-TETRAHYDRO-QUINAZOLINE-2-YL COMPOUNDS Grünenthal GmbH (DE) 2007-01-17 EP disclosed
WO-2005105759-A1 SUBSTITUTED 5, 6, 7, 8-TETRAHYDRO-PYRIDO[4, 3-D]PYRIMIDINE-2-YL COMPOUNDS AND 5, 6, 7, 8-TETRAHYDRO-QUINAZOLINE-2-YL COMPOUNDS Grünenthal GmbH (DE) 2005-11-10 WO disclosed